Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Smriti
    Member
    • Mar 2011
    • 40

    #1

    Is Nextera useful for Pac bio in future?

    Hi There,

    I am working with Nextera workflow. I was wondering if Nextera library prep can be somehow extended to Pac bio platform. My understanding is Nextera insert size is much smaller than what Pac bio can sequence. Is there a way Nextera transposon can fragment a bigger size insert, add adapters and then it gets sequenced on Pac bio.

    This way, we can use advantage of both the technologies, low imput starting material and sequencing it real-time.

    Any suggestions?
  • SNPsaurus
    Registered Vendor
    • May 2013
    • 525

    #2
    I suspect that if you were to reduce the amount of transposase compared to DNA then you would see an increase in the bias of the fragmentation, as the preferred sites would use up the low amount of reagent.

    Nextera is nice because it allows you to skip end-repair and ligation of adapters. But if you want to make really long DNA fragments, it is probably preferable to just end repair and ligate and not add a fragmentation step.
    Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

    Comment

    • nucacidhunter
      Jafar Jabbari
      • Jan 2013
      • 1250

      #3
      It can be done in two ways. One is to do tagmentation with more input DNA or reduced enzyme to obtain large tagmented DNA for amplification as suggested by SNPsaurus. Other is to tagment DNA as before but fill in the gap and end repair without amplification. One also can introduce size selection either way. Nextera mate pair tagmentation system also can be used but it is less cost effective.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Working...